CD40LG and metabolic dysfunction-associated steatotic liver disease: Soluble CD40L levels are increased in NAFLD patients [39], and peripheral blood gene sequencing showed that CD40/CD40L signaling was one of the four major pathways upregulated in individuals with fatty liver [40].